Evidence map›Paper›PMID 34670092›Full record

ArticleJournal of proteome research2021

Progress Identifying and Analyzing the Human Proteome: 2021 Metrics from the HUPO Human Proteome Project.

Gilbert S Omenn, Lydie Lane, Christopher M Overall, Young-Ki Paik, Ileana M Cristea, Fernando J Corrales, Cecilia Lindskog, Susan Weintraub, Michael H A Roehrl, Siqi Liu and 6 more

Open access · greenAbstract read
In one paragraph

Article in Journal of proteome research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. CLASPP: A unified model for predicting post-translational modifications.bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Human Plasma Proteome During Normal Pregnancy.Journal of proteome research · 2022
    Article
  19. In Depth Exploration of the Alternative Proteome ofFrontiers in cell and developmental biology · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 15 institutions in 8 countries.

Gilbert S OmennUniversity of Michigan, Ann Arbor, Michigan 48109, United States.ORCID 0000-0002-8976-6074
Lydie LaneCALIPHO Group, SIB Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland.ORCID 0000-0002-9818-3030
Christopher M OverallUniversity of British Columbia, Vancouver, BC V6T 1Z4, Canada.
Young-Ki PaikYonsei Proteome Research Center and Yonsei University, Seoul 03722, Korea.ORCID 0000-0002-8146-1751
Ileana M CristeaPrinceton University, Princeton, New Jersey 08544, United States.ORCID 0000-0002-6533-2458
Fernando J CorralesCentro Nacional de Biotecnologia, 28049 Madrid, Spain.ORCID 0000-0002-0231-5159
Cecilia LindskogUppsala University, 752 36 Uppsala, Sweden.ORCID 0000-0001-5611-1015
Susan WeintraubUniversity of Texas Health, San Antonio, San Antonio, Texas 78229-3900, United States.ORCID 0000-0002-8328-7814
Michael H A RoehrlMemorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
Siqi LiuBGI Group, Shenzhen 518083, China.ORCID 0000-0001-9744-3681
Nuno BandeiraUniversity of California, San Diego, La Jolla, California 92093, United States.ORCID 0000-0001-8385-3655
Sudhir SrivastavaNational Cancer Institute, Rockville, Maryland 20850, United States.
Yu-Ju ChenNational Taiwan University, Academia Sinica, Nankang, Taipei 11529, Taiwan.ORCID 0000-0002-3178-6697
Ruedi AebersoldETH-Zurich and University of Zurich, 8092 Zurich, Switzerland.
Robert L MoritzInstitute for Systems Biology, Seattle, Washington 98109, United States.ORCID 0000-0002-3216-9447
Eric W DeutschInstitute for Systems Biology, Seattle, Washington 98109, United States.ORCID 0000-0001-8732-0928
Institute for Systems Biology · USBGI Group (China) · CNCentro Nacional de Biotecnología · ESMemorial Sloan Kettering Cancer Center · USNational Cancer Institute · USNational Taiwan University · TWPrinceton University · USSIB Swiss Institute of Bioinformatics · CHThe University of Texas Health Science Center at San Antonio · USUniversity of British Columbia · CAUniversity of California San Diego · USUniversity of Michigan · USUniversity of Zurich · CHUppsala University · SEYonsei University · KR

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Systems BiologyU19AG023122 · NIA · TRANSLATIONAL GENOMICS RESEARCH INST · PI Thomas Girke, NICHOLAS Joseph SCHORK · 2004 to 2026
$102.6M
Strategic Vision & Impact on Environmental HealthP30ES017885 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Dana Dolinoy · 2011 to 2026
$21.3M
Shortening the development cycle time of Trans Proteomic Pipeline tools with high performance computingR01GM087221 · NIGMS · INSTITUTE FOR SYSTEMS BIOLOGY · PI DEUTSCH, ERIC, MORITZ, ROBERT L · 2010 to 2021
$6.0M
University of Michigan Proteogenomics Data Analysis CenterU24CA210967 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHINNAIYAN, ARUL M, DHANASEKARAN, SARAVANA M · 2016 to 2020
$4.1M
Integrative Omics to enhance therapeutics development for healthy agingUH3AG064706 · NIA · TRANSLATIONAL GENOMICS RESEARCH INST · PI MILLER, RICHARD A, SCHORK, NICHOLAS JOSEPH · 2021 to 2024
$3.3M
Mechanisms mediating immune response upon sensing of nuclear viral DNAR01GM114141 · NIGMS · PRINCETON UNIVERSITY · PI CRISTEA, ILEANA M. · 2015 to 2023
$2.6M
Evaluation of the effect of patient-context factors and sample acquisition on the quality and analytical performance of cell-free DNA and circulating tumor cells profiling assays in prostate cancer paU01CA253217 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI ARCILA, MARIA E, SCHER, HOWARD I · 2020 to 2024
$1.8M
Advancing data and metadata standards for proteomics mass spectraR24GM127667 · NIGMS · INSTITUTE FOR SYSTEMS BIOLOGY · PI DEUTSCH, ERIC · 2017 to 2019
$1.2M
Proteomic Characterization of Genomically Complex SarcomasR21CA251992 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI ROEHRL, MICHAEL H. A. · 2020 to 2020
$487k
Proteomic Characterization of Pancreatic Neuroendocrine Tumors and Metastatic ProgressionR21CA263262 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI ROEHRL, MICHAEL H. A. · 2021 to 2022
$450k
Symposium on Extracellular and Membrane Proteases in Cell SignalingR13CA135997 · NCI · IOWA STATE UNIVERSITY · PI BLOBEL, GUNTER, HUNG, MIEN-CHIE · 2008 to 2008
$15k
NCI NIH HHS P30 CA008748NCI NIH HHS R13 CA135997NCI NIH HHS R21 CA251992NCI NIH HHS R21 CA263262NCI NIH HHS U01 CA253217NCI NIH HHS U24 CA210967NIA NIH HHS U19 AG023122NIA NIH HHS UH3 AG064706NIEHS NIH HHS P30 ES017885NIGMS NIH HHS R01 GM087221NIGMS NIH HHS R01 GM114141NIGMS NIH HHS R24 GM127667
6 · The paper itself

Abstract

The 2021 Metrics of the HUPO Human Proteome Project (HPP) show that protein expression has now been credibly detected (neXtProt PE1 level) for 18 357 (92.8%) of the 19 778 predicted proteins coded in the human genome, a gain of 483 since 2020 from reports throughout the world reanalyzed by the HPP. Conversely, the number of neXtProt PE2, PE3, and PE4 missing proteins has been reduced by 478 to 1421. This represents remarkable progress on the proteome parts list. The utilization of proteomics in a broad array of biological and clinical studies likewise continues to expand with many important findings and effective integration with other omics platforms. We present highlights from the Immunopeptidomics, Glycoproteomics, Infectious Disease, Cardiovascular, Musculo-Skeletal, Liver, and Cancers B/D-HPP teams and from the Knowledgebase, Mass Spectrometry, Antibody Profiling, and Pathology resource pillars, as well as ethical considerations important to the clinical utilization of proteomics and protein biomarkers.

Indexed as

BenchmarkingProteomeDatabases, ProteinHumansMass SpectrometryProteomicsProteomeBiology and Disease-HPP (B/D-HPP)Chromosome-centric HPP (C-HPP)Human Protein AtlasHuman Proteome Project (HPP)Mass Spectrometry Interactive Virtual Environment (MassIVE)missing proteins (MP)neXtProt protein existence (PE) metricsnon-MS PE1 proteinsPeptideAtlasuncharacterized protein existence 1 (uPE1)

Identifiers

PMID34670092
PMCPMC9340669
OpenAlexW3207926977

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.